Development of human embryonic cell lines

Information

  • Research Project
  • 6617063
  • ApplicationId
    6617063
  • Core Project Number
    R43DK065133
  • Full Project Number
    1R43DK065133-01
  • Serial Number
    65133
  • FOA Number
    PAR-02-023
  • Sub Project Id
  • Project Start Date
    1/1/2003 - 22 years ago
  • Project End Date
    12/31/2003 - 21 years ago
  • Program Officer Name
    KELTY, MIRIAM F.
  • Budget Start Date
    1/1/2003 - 22 years ago
  • Budget End Date
    12/31/2003 - 21 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -
Organizations

Development of human embryonic cell lines

[unreadable] DESCRIPTION (provided by applicant): The goal of this proposed project is to establish the infrastructure to develop, characterize, and share useful human embryonic stem cell lines from the group of derivations designated CY12, CY30, CY40, CY51, CY81, CY82, CY91, CY92, and CY10 on the NIH Human Embryonic Stem Cell Registry. These cells meet the federal criteria for funding. The cells are at a very early stage of development. They were frozen at early passage, and exist now as frozen specimens; there is one vial of CY12 and of CY92, but there are at least two, and as many as 6 frozen vials of the others. The cells have been passaged up to 5 times, and have given rise to alkaline phosphatase-positive colonies. Since the cells are part of a limited resource, the first aim is a cautious approach to developing conditions that allow survival of the cells. The other 3 aims are to characterize the cells and provide them to researchers. Specific Aim 1: Establish culture conditions for recovery, expansion, and production of clonal lines of early stage human derivations. Using established hES cell lines, we will evaluate and improve if necessary the co-culture methods used for the initial derivation of the cells. Specific Aim 2: Establish cell lines from early stage human derivations and characterize them by standard criteria. We will use the methods developed in Aim l to recover cells from the derivations, and use the standard criteria for identifying the cells as ES cells. Specific Aim 3: Genotype and phenotype the hES cell lines. We will use microsatellite genotyping and a simple SNP screen to obtain genetic information about the cells. We will phenotype the cells by limited microarray analysis similar to that done for mouse ES cells, and confirm and extend the microarray results with quantitative RTPCR. Specific Aim 4: Expand hES cell lines and provide them to other laboratories. We plan to distribute the cells to other researchers and share our expertise in order to help in establishing uniform standards. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    93944
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:93944\
  • Funding Mechanism
  • Study Section
    ZDC1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CYTHERA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921211122
  • Organization District
    UNITED STATES